ID: ALA2086581

Max Phase: Preclinical

Molecular Formula: C35H42N8O4

Molecular Weight: 638.77

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)Cn2cc(-c3ccc(-n4cnc5c(N)ncnc54)cc3)nn2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C35H42N8O4/c1-6-33(4)15-26(34(5)20(2)11-13-35(21(3)30(33)46)14-12-25(44)29(34)35)47-27(45)17-42-16-24(40-41-42)22-7-9-23(10-8-22)43-19-39-28-31(36)37-18-38-32(28)43/h6-10,16,18-21,26,29-30,46H,1,11-15,17H2,2-5H3,(H2,36,37,38)/t20-,21+,26-,29+,30+,33-,34+,35+/m1/s1

Standard InChI Key:  QZUTTXSQDMFTQC-OPQGOLPDSA-N

Associated Targets(non-human)

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Listeria innocua 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus subtilis 32866 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 638.77Molecular Weight (Monoisotopic): 638.3329AlogP: 4.56#Rotatable Bonds: 6
Polar Surface Area: 163.93Molecular Species: NEUTRALHBA: 12HBD: 2
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.35CX LogP: 4.55CX LogD: 4.55
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.23Np Likeness Score: 0.58

References

1. Dreier I, Kumar S, Søndergaard H, Rasmussen ML, Hansen LH, List NH, Kongsted J, Vester B, Nielsen P..  (2012)  A click chemistry approach to pleuromutilin derivatives, part 2: conjugates with acyclic nucleosides and their ribosomal binding and antibacterial activity.,  55  (5): [PMID:22280300] [10.1021/jm201266b]
2. Dreier I, Hansen LH, Nielsen P, Vester B..  (2014)  A click chemistry approach to pleuromutilin derivatives. Part 3: extended footprinting analysis and excellent MRSA inhibition for a derivative with an adenine phenyl side chain.,  24  (4): [PMID:24486133] [10.1016/j.bmcl.2014.01.019]
3. Heidtmann CV,Voukia F,Hansen LN,Sørensen SH,Urlund B,Nielsen S,Pedersen M,Kelawi N,Andersen BN,Pedersen M,Reinholdt P,Kongsted J,Nielsen CU,Klitgaard JK,Nielsen P.  (2020)  Discovery of a Potent Adenine-Benzyltriazolo-Pleuromutilin Conjugate with Pronounced Antibacterial Activity against MRSA.,  63  (24): [PMID:33325700] [10.1021/acs.jmedchem.0c01328]

Source